Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
146.40
-0.42 (-0.29%)
Streaming Delayed Price
Updated: 10:29 AM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
April 17, 2024
Johnson & Johnson reports first-quarter earnings, with adjusted EPS up 12.4% and sales up 2.3%. Analysts optimistic about stock's future, highlighting potential growth from new drug approvals. JNJ aims...
Via
Benzinga
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
April 17, 2024
Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday.
Via
Benzinga
Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
April 17, 2024
Although monetary policy seemed to be moving in a dovish direction, a pivot may warrant a look at stocks for Fed hikes.
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
Put $10,000 in These 3 Dividend Stocks by 2025
April 17, 2024
In market uncertainty, dividend stocks come to the rescue. Rebalance your portfolio with these three dividend stocks and enjoy steady income.
Via
InvestorPlace
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
April 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
A Closer Look at 9 Analyst Recommendations For Johnson & Johnson
April 15, 2024
Via
Benzinga
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
April 17, 2024
Johnson & Johnson's Q1 2024 earnings offer a mixed picture of resilience amidst economic headwinds and provide insight into the broader medtech sector's health.
Via
MarketBeat
Topics
Economy
Exposures
COVID-19
Supply Chain
Why Johnson & Johnson Stock Got Tossed by the Market Today
April 16, 2024
A mixed quarter and narrowed guidance didn't really please investors.
Via
The Motley Fool
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
April 16, 2024
JNJ earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
April 16, 2024
Investors remain on edge as geopolitics continue to shape market trends, with Israel mulling a response to Iran while the U.S. and key allies explore further sanctions against Tehran.
Via
Benzinga
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
April 16, 2024
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost...
Via
Benzinga
JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024
April 16, 2024
JNJ stock results show that Johnson & Johnson beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook
April 16, 2024
Johnson & Johnson reports Q1 results: adjusted EPS $2.71 (up 12.4% Y/Y), sales $21.38B (up 2.3% Y/Y). Explore pharma giant's robust performance, including strong growth in Innovative Medicine and...
Via
Benzinga
Johnson & Johnson is as Cheap as it’s Going to Get
April 16, 2024
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely.
Via
MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
April 16, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
Bellwether Health Giant J&J Beats Earnings Calls, But Shares Dip On Light Sales
April 16, 2024
The company reported light first-quarter sales, though earnings came in narrowly ahead.
Via
Investor's Business Daily
Earnings Turnaround For Johnson & Johnson With Q1 2024 Financial Results
April 16, 2024
Pharmaceutical and consumer staples titan Johnson & Johnson reported its Q1 2024 financial results this morning.
Via
Talk Markets
Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges
April 16, 2024
Profit from corporate cash splurges with these top ETFs targeting buyback strategies. Unlock potential gains in a volatile market.
Via
InvestorPlace
Topics
ETFs
Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
April 16, 2024
Earnings optimism may partly offset worries concerning rising bond yields and the volatile geopolitical situation in the Middle East, with the index futures trading mixed early
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
Earnings Scheduled For April 16, 2024
April 16, 2024
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to report earnings for its fourth quarter.
Via
Benzinga
Star Surgical Shines as U.S. Outlook Improves for 2024
April 16, 2024
STAAR Surgical is increasing its outlook and guidance as demand for its signature IOL procedure increases with an aging population
Via
MarketBeat
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
April 16, 2024
From
Johnson & Johnson
Via
Business Wire
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Healthcare stocks disappointed again last week with the XLV down over 3% and up only 1.65 % YTD, in a continued downtrend since March 28.
Via
Talk Markets
Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
April 16, 2024
Johnson & Johnson (NYSE: JNJ) is set to release earnings results for its first quarter before the opening bell on April 16, 2024.
Via
Benzinga
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday
April 16, 2024
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%
April 16, 2024
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the "Fear" zone on Monday. U.S. stocks closed lower on Friday amid concerns over the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
J&J Braces For Q1 Earnings With Bearish Charts And Patent Cliffs In Play
April 15, 2024
Johnson & Johnson's Q1 earnings report on April 16 is expected to show $2.64 EPS and $21.4 billion in revenues. Technical analysis shows a bearish trend but analysts have a neutral rating with a...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
April 15, 2024
BofA Securities' upgrades Integer, highlighting the growth potential of pulsed field ablation (PFA) in atrial fibrillation treatment. With projections of PFA sales skyrocketing from $100-200 million in...
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
April 15, 2024
From
Brodsky & Smith LLC
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.